ATE85345T1 - Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung. - Google Patents

Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Info

Publication number: ATE85345T1
Authority: AT; Austria
Prior art keywords: fragment; anf; cdd; arg; ser
Prior art date: 1987-03-02

Application number

AT88901838T

Other languages

English (en)

Inventor

Wolf-Georg Forssmann

Jeanette M Alt

Gerhard Becker

Franz Herbst

Original Assignee

Forssmann Wolf Georg

Bissendorf Peptide Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-02

Filing date

1988-02-27

Publication date

1993-02-15

1987-03-02 Priority claimed from DE19873706731 external-priority patent/DE3706731A1/de

1987-05-22 Priority claimed from DE19873717329 external-priority patent/DE3717329A1/de

1988-02-27 Application filed by Forssmann Wolf Georg, Bissendorf Peptide Gmbh filed Critical Forssmann Wolf Georg

1993-02-15 Application granted granted Critical

1993-02-15 Publication of ATE85345T1 publication Critical patent/ATE85345T1/de

Links

239000012634 fragment Substances 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
102400001279 Urodilatin Human genes 0.000 abstract 4
IUCCYQIEZNQWRS-DWWHXVEHSA-N ularitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 IUCCYQIEZNQWRS-DWWHXVEHSA-N 0.000 abstract 4
108010033276 Peptide Fragments Proteins 0.000 abstract 3
102000007079 Peptide Fragments Human genes 0.000 abstract 3
150000001413 amino acids Chemical group 0.000 abstract 3
108010001957 Ularitide Proteins 0.000 abstract 2
101800001849 Urodilatin Proteins 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
210000003734 kidney Anatomy 0.000 abstract 1
238000011084 recovery Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

AT88901838T 1987-03-02 1988-02-27 Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung. ATE85345T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE19873706731 DE3706731A1 (de)	1987-03-02	1987-03-02	Neues cardiodilatinfragment und verfahren zur gewinnung von cardiodilatinfragmenten
DE19873717329 DE3717329A1 (de)	1987-05-22	1987-05-22	Neues cardiodilatinfragment, verfahren zu seiner gewinnung und seine verwendung
DE3741641		1987-12-09
PCT/EP1988/000144 WO1988006596A1 (en)	1987-03-02	1988-02-27	New cardiodilatin fragment, process for preparing same and use thereof
EP88901838A EP0349545B1 (de)	1987-03-02	1988-02-27	Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung

Publications (1)

Publication Number	Publication Date
ATE85345T1 true ATE85345T1 (de)	1993-02-15

Family

ID=27195544

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88901838T ATE85345T1 (de)	1987-03-02	1988-02-27	Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Country Status (7)

Country	Link
EP (1)	EP0349545B1 (de)
JP (1)	JP2819467B2 (de)
AT (1)	ATE85345T1 (de)
AU (1)	AU614738B2 (de)
DE (1)	DE3878231T2 (de)
DK (1)	DK174112B1 (de)
WO (1)	WO1988006596A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5262521A (en) *	1991-06-07	1993-11-16	Sri International	Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
DE4216133A1 (de) *	1992-05-15	1993-11-18	Bissendorf Peptide Gmbh	Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen
US5665704A (en) *	1993-11-12	1997-09-09	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US6525022B1 (en)	1993-11-12	2003-02-25	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US5846932A (en) *	1993-11-12	1998-12-08	Genentech, Inc.	Receptor specific atrial natriuretic peptides
AU2671795A (en) *	1994-06-02	1996-01-04	Boehringer Mannheim Gmbh	Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
DE19535445A1 (de) *	1995-09-23	1997-03-27	Boehringer Mannheim Gmbh	Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine
WO1997018314A1 (de) *	1995-11-16	1997-05-22	Boehringer Mannheim Gmbh	Verfahren zur herstellung von peptiden über streptavidin-fusionsproteine
DE19951471A1 (de) *	1999-10-26	2001-05-03	Forssmann Wolf Georg	Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
DE10116552A1 (de)	2001-04-03	2002-10-10	Abc Armbruster Biochemicals	Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
PL1865976T3 (pl)	2005-04-07	2012-11-30	Cardiorentis Ag	Zastosowanie peptydu natriuretycznego do leczenia niewydolności serca
EP2004633A4 (de)	2006-03-30	2009-08-26	Palatin Technologies Inc	Lineare natriuretische peptidkonstrukte
CA2647143A1 (en)	2006-03-30	2007-10-11	Palatin Technologies, Inc.	Cyclic natriuretic peptide constructs
US8580746B2 (en)	2006-03-30	2013-11-12	Palatin Technologies, Inc.	Amide linkage cyclic natriuretic peptide constructs
EP2185183B1 (de) *	2007-09-11	2016-03-16	Cardiopep Pharma GmbH	Verwendung von natriuretischen peptiden zur behandlung von angioödemen
EP2631247A1 (de)	2012-02-22	2013-08-28	Immundiagnostik AG	Mittel und Verfahren zum Messen des Parathyroid-Hormons bei unter oxidativem Stress leidenden Patienten
EP2775306B1 (de)	2013-03-08	2018-06-27	Immundiagnostik AG	Nicht oxidiertes, biologisch aktives Parathormon zur Bestimmung der Sterblichkeit bei Hämodialysepatienten
WO2019141791A1 (en)	2018-01-17	2019-07-25	Immundiagnostik Ag	Biomarker predicting coronary artery disease
FR3099056B1 (fr) *	2019-07-26	2022-08-12	Univ Rouen Normandie	Utilisation de l’ANP pour détruire les biofilms bactériens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3588006T2 (de) *	1984-04-19	1995-08-10	Scios Nova Inc	Atrielle natriumuretische/gefässerweiterende polypeptide.
DE3443257A1 (de) *	1984-11-28	1986-05-28	Bissendorf Peptide GmbH, 3002 Wedemark	Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)

1988
- 1988-02-27 WO PCT/EP1988/000144 patent/WO1988006596A1/en not_active Ceased
- 1988-02-27 DE DE8888901838T patent/DE3878231T2/de not_active Expired - Lifetime
- 1988-02-27 AU AU13481/88A patent/AU614738B2/en not_active Expired
- 1988-02-27 JP JP63502001A patent/JP2819467B2/ja not_active Expired - Lifetime
- 1988-02-27 AT AT88901838T patent/ATE85345T1/de not_active IP Right Cessation
- 1988-02-27 EP EP88901838A patent/EP0349545B1/de not_active Expired - Lifetime
- 1988-11-02 DK DK198806108A patent/DK174112B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2819467B2 (ja)	1998-10-30
AU1348188A (en)	1988-09-26
EP0349545A1 (de)	1990-01-10
JPH02502636A (ja)	1990-08-23
WO1988006596A1 (en)	1988-09-07
DK610888A (da)	1988-11-02
EP0349545B1 (de)	1993-02-03
DE3878231T2 (de)	1993-05-27
AU614738B2 (en)	1991-09-12
DK610888D0 (da)	1988-11-02
DK174112B1 (da)	2002-06-24
DE3878231D1 (de)	1993-03-18

Similar Documents

Publication	Publication Date	Title
ATE85345T1 (de)	1993-02-15	Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
PT93910A (pt)	1991-01-08	Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
TR199802789T2 (xx)	1999-03-22	Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
GEP20033002B (en)	2003-06-25	Osteoprotegerin Binding Protein and Receptors
RU94046251A (ru)	1996-10-27	Глюкагоноподобный пептид и производные инсулино-тропина, способ получений, фармацевтические композиции, способы лечения диабета
ATE75483T1 (de)	1992-05-15	Oligonukleotides heilmittel und dessen herstellungsverfahren.
ATE32728T1 (de)	1988-03-15	Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
HUT58813A (en)	1992-03-30	Process for producing tissue-plasminogen activator derivative
HUT46061A (en)	1988-09-28	Dna sequences encoding hirudin-like protein and process for producing such proteins
DK162233C (da)	1992-03-16	Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
ATA309588A (de)	1997-04-15	Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform
BR9807618A (pt)	2000-02-15	Análogo de fator xdelta, dna recombinante codificante para um análogo de fator xdelta, células transformadas, preparação, uso da mesma, e, processos para produzir uma preparação contendo análogo de fator xdelta recombinante purificado e análogo de fator xa.
AU617989B2 (en)	1991-12-12	Variants of hirudin, their use and their preparation
SE9501472D0 (sv)	1995-04-21	Truncated IGF-I
DK482185A (da)	1986-04-23	Peptider, deres fremstilling og anvendelse som laegemidler
EP0546087A4 (de)	1994-01-05
AU1987088A (en)	1989-01-19	A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
ES2170144T3 (es)	2002-08-01	Variantes que no se empalman de gp350/220.
KR880011200A (ko)	1988-10-27	텐다미스탵 유도체
WO1990003394A3 (fr)	1990-07-12	Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
AR018532A1 (es)	2001-11-28	Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
ES8204713A1 (es)	1982-05-16	Un procedimiento para aislar un polipeptido purificado
PT88913A (pt)	1988-12-01	Processo para a preparacao da proteina pp4-x anticoagulante
PL321890A1 (en)	1997-12-22	Variants human dnase i
DK0580782T3 (da)	1998-05-04	Anti-HIV-protein, TAP 29, fra Trichosanthes, DNA, som koder derfor, og terapeutiske anvendelser deraf

Legal Events

Date	Code	Title	Description
1993-08-15	UEP	Publication of translation of european patent specification
2003-11-15	REN	Ceased due to non-payment of the annual fee